Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy in treating pediatric patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
Phase 2
- Conditions
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Registration Number
- JPRN-UMIN000000545
- Lead Sponsor
- Japanese Pediatric Brain Tumor Consortium
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Has double cancer. Has cardiac disease for which treatment is necessary.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year progression-free survival
- Secondary Outcome Measures
Name Time Method 3-year overall survival